Duke University Medical Center - Division of Hematologic Malignancies — Durham, North Carolina

Duke University Medical Center - Division of Hematologic Malignancies is a clinical research site located in Durham, North Carolina, United States 27705.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Duke University Medical Center - Division of Hematologic Malignancies has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL).

Sponsors: Miltenyi Biomedicine GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

• Duke University Medical Center- Duke Integrative Medicine
• Duke University Clinic
• The Brain Tumor Center at Duke, Duke University Medical Center
• Duke University Eye Center; Vitreoretinal
• Duke University - Duke Children's Hospital & Health Center
• Durham Veterans Administration
• Duke University Medical Denter
• Duke University Medical Center / Civitan Building
• Duke University Medical Center, Children's Health Center
• Duke University School of Medicine - Dept. of Ophthalmology
• Duke University Medical Center, Duke Infectious Diseases
• Duke University Medical Center /ID# 214435

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Medical Center - Division of Hematologic Malignancies?

Duke University Medical Center - Division of Hematologic Malignancies has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Medical Center - Division of Hematologic Malignancies conducted?

Duke University Medical Center - Division of Hematologic Malignancies has 1 clinical trials on record, with 1 currently active. Their work covers Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL).

Is Duke University Medical Center - Division of Hematologic Malignancies accredited by Crixeo Clinical Trials?

Duke University Medical Center - Division of Hematologic Malignancies has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Medical Center - Division of Hematologic Malignancies?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.